Individual/Population Bioequivalence [General Sta­tis­tics]

posted by Harish Kaushik – India, 2015-02-02 13:16 (3343 d 01:05 ago) – Posting: # 14350
Views: 9,421

Hello HS & Forum members

I have read in a BEBAC forum posted by HS that the concept of Individual/Population Bioequivalence is no longer considered by FDA/other regulatory agencies, Is it true?

If I understand rightly, FDA/EMEA considers only Average bioequivalence for establishing the BE of formulations?

Correct me if iam wrong, may be this is reason why in bear software we don't have option to calculate IBE/PBE

Finally, I would like to hear from experts out there, about the status of IBE/PBE statistical analysis, Does it have any relevance now?

Regards
Kaushik

Complete thread:

UA Flag
Activity
 Admin contact
22,957 posts in 4,819 threads, 1,636 registered users;
108 visitors (0 registered, 108 guests [including 8 identified bots]).
Forum time: 14:22 CET (Europe/Vienna)

With four parameters I can fit an elephant,
and with five I can make him wiggle his trunk.    John von Neumann

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5